1. Comparative effectiveness of oseltamivir versus peramivir for hospitalized children (aged 0-5 years) with influenza infection
- Author
-
Ming Xu, Ting Cai, Tingting Yue, Pan Zhang, Jie Huang, Qi Liu, Yue Wang, Ruping Luo, Zhengqiu Li, Linli Luo, Chunyi Ji, Xinrui Tan, Yanling Zheng, Richard Whitley, Erik De Clercq, Qiang Yin, and Guangdi Li
- Subjects
Microbiology (medical) ,Infectious Diseases ,General Medicine - Abstract
Effectiveness of oseltamivir versus peramivir in influenza-infected children remains unclear. This study aims to evaluate their effectiveness in young children (ages 0-5 years) infected with severe influenza A virus (IAV) or influenza B virus (IBV).We analyzed a cohort of 1662 young children with either IAV (N=1095) or IBV (N=567) who received oseltamivir or peramivir treatment from January 1, 2018 to March 31, 2022. Propensity score matching methods were applied to match oseltamivir-treated versus peramivir-treated children.IAV-infected and IBV-infected children shared similar features such as influenza-associated symptoms and comorbidities at baseline. Among IAV-infected children with bacterial coinfection, the recovery rate was significantly greater in oseltamivir-treated children than in peramivir-treated children (15.6% versus 4.4%, p=0.01). The median duration of hospitalization was also shorter in oseltamivir-treated children. Among IAV-infected children without bacterial coinfection, the recovery rate was greater in oseltamivir-treated children than in peramivir-treated children (21.1% versus 3.7%, p=0.002). However, oseltamivir and peramivir offered similar recovery rates and duration of hospitalization (p0.05 for both) among IBV-infected children.Oseltamivir and peramivir exhibit similar effectiveness in young children with severe influenza B, whereas oseltamivir demonstrated improved recovery and shorter hospitalization in the treatment of severe influenza A in hospitalized children.
- Published
- 2023
- Full Text
- View/download PDF